Acceleron Pharma
Utility Patent Applications

Last updated:

List of all Acceleron Pharma patents 88 in total

Status Patent
Application
Utility: VARIANTS DERIVED FROM ACTRIIB AND USES THEREFOR External link
Filling date: 8 Sep 2025 Issue date: 8 Sep 2022
Application
Utility: COMPOSITIONS AND METHOD FOR TREATING KIDNEY DISEASE External link
Filling date: 8 Sep 2025 Issue date: 18 Aug 2022
Application
Utility: ALK4:ACTRIIB HETEROMULTIMERS AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 4 Aug 2022
Application
Utility: ACTRII-BINDING PROTEINS AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 4 Aug 2022
Application
Utility: METHODS FOR INCREASING RED BLOOD CELL LEVELS AND TREATING INEFFECTIVE ERYTHROPOIESIS External link
Filling date: 8 Sep 2025 Issue date: 28 Jul 2022
Application
Utility: METHOD FOR PROMOTING BONE GROWTH USING ACTIVIN-ACTRIIA ANTAGONISTS External link
Filling date: 8 Sep 2025 Issue date: 7 Jul 2022
Application
Utility: METHODS FOR TREATING HETEROTOPIC OSSIFICATION External link
Filling date: 8 Sep 2025 Issue date: 7 Jul 2022
Application
Utility: ACTIVIN-ACTRII ANTAGONISTS AND USES FOR INCREASING RED BLOOD CELL LEVELS External link
Filling date: 8 Sep 2025 Issue date: 30 Jun 2022
Application
Utility: TRUNCATED ACTRIIB-FC FUSION PROTEINS External link
Filling date: 8 Sep 2025 Issue date: 2 Jun 2022
Application
Utility: METHODS AND COMPOSITIONS FOR TREATING ULCERS External link
Filling date: 8 Sep 2025 Issue date: 5 May 2022
Application
Utility: BMP-ALK3 ANTAGONISTS AND USES FOR PROMOTING BONE GROWTH External link
Filling date: 8 Sep 2025 Issue date: 28 Apr 2022
Application
Utility: METHODS FOR DOSING AN ACTRIIB ANTAGONIST AND MONITORING OF TREATED PATIENTS External link
Filling date: 8 Sep 2025 Issue date: 21 Apr 2022
Application
Utility: ACTRIIB BINDING AGENTS AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 31 Mar 2022
Application
Utility: ISOLATED GDF TRAP POLYPEPTIDE External link
Filling date: 8 Sep 2025 Issue date: 31 Mar 2022
Application
Utility: BI-AND TRI-FUNCTIONAL FUSION PROTEINS AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 24 Mar 2022
Application
Utility: COMPOSITIONS AND METHODS FOR TREATING SPINAL MUSCULAR ATROPHY External link
Filling date: 8 Sep 2025 Issue date: 24 Mar 2022
Application
Utility: ACTRIIB PROTEINS AND VARIANTS AND USES THEREFORE RELATING TO UTROPHIN INDUCTION FOR MUSCULAR DYSTROPHY THERAPY External link
Filling date: 8 Sep 2025 Issue date: 10 Feb 2022
Application
Utility: METHODS FOR INCREASING THERMOGENIC ADIPOCYTES External link
Filling date: 8 Sep 2025 Issue date: 20 Jan 2022
Application
Utility: METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS AND PERICYTE COMPOSITION External link
Filling date: 8 Sep 2025 Issue date: 20 Jan 2022
Application
Utility: METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS AND PERICYTE COMPOSITION External link
Filling date: 8 Sep 2025 Issue date: 16 Dec 2021
Application
Utility: NOVEL BINDERS OF TGFBeta-SUPERFAMILY LIGANDS AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 9 Dec 2021
Application
Utility: ALK4:ACTRIIB HETEROMULTIMERS AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 25 Nov 2021
Application
Utility: ACTIVIN-ACTRII ANTAGONISTS AND USES FOR INCREASING RED BLOOD CELL LEVELS External link
Filling date: 8 Sep 2025 Issue date: 18 Nov 2021
Application
Utility: ANTAGONISTS OF ACTIVIN-ACTRIIA AND USES FOR INCREASING RED BLOOD CELL LEVELS External link
Filling date: 8 Sep 2025 Issue date: 18 Nov 2021
Application
Utility: TREATMENT OF ANEMIA DUE TO VERY LOW, LOW, OR INTERMEDIATE RISK MYELODYSPLASTIC SYNDROMES IN SUBJECTS WITH RING SIDEROBLASTS USING ACTIVIN-ACTRll LIGAND TRAPS External link
Filling date: 8 Sep 2025 Issue date: 11 Nov 2021
Application
Utility: ALK7 BINDING PROTEINS AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 21 Oct 2021
Application
Utility: TGF-BETA RECEPTOR TYPE II FUSION PROTEINS AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 21 Oct 2021
Application
Utility: METHODS AND COMPOSITIONS FOR TREATING MYELOFIBROSIS External link
Filling date: 8 Sep 2025 Issue date: 21 Oct 2021
Application
Utility: ACTIVIN TYPE 2 RECEPTOR BINDING PROTEINS AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 7 Oct 2021
Application
Utility: COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION External link
Filling date: 8 Sep 2025 Issue date: 30 Sep 2021
Application
Utility: COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION External link
Filling date: 8 Sep 2025 Issue date: 30 Sep 2021
Application
Utility: ENDOGLIN POLYPEPTIDES AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 30 Sep 2021
Application
Utility: METHODS AND COMPOSITIONS FOR INCREASING RED BLOOD CELLS External link
Filling date: 8 Sep 2025 Issue date: 9 Sep 2021
Application
Utility: METHODS FOR TREATING FATTY LIVER DISEASE External link
Filling date: 8 Sep 2025 Issue date: 2 Sep 2021
Application
Utility: ACTIVIN-ACTRIIA ANTAGONISTS AND USES FOR TREATING MULTIPLE MYELOMA External link
Filling date: 8 Sep 2025 Issue date: 26 Aug 2021
Application
Utility: COMBINED USE OF GDF TRAPS AND ERYTHROPOIETIN RECEPTOR ACTIVATORS TO INCREASE RED BLOOD CELL LEVELS External link
Filling date: 8 Sep 2025 Issue date: 19 Aug 2021
Application
Utility: TGF-BETA RECEPTOR TYPE II VARIANTS AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 29 Jul 2021
Application
Utility: METHODS FOR TREATING MYELODYSPLASTIC SYNDROMES AND SIDEROBLASTIC ANEMIAS External link
Filling date: 8 Sep 2025 Issue date: 29 Jul 2021
Application
Utility: METHODS AND COMPOSITIONS FOR TREATING INEFFECTIVE ERYTHROPOIESIS External link
Filling date: 8 Sep 2025 Issue date: 8 Jul 2021
Application
Utility: METHODS FOR INCREASING RED BLOOD CELL LEVELS AND TREATING SICKLE-CELL DISEASE External link
Filling date: 8 Sep 2025 Issue date: 24 Jun 2021
Application
Utility: METHODS AND COMPOSITIONS FOR TREATMENT OF DISORDERS WITH FOLLISTATIN POLYPEPTIDES External link
Filling date: 8 Sep 2025 Issue date: 17 Jun 2021
Application
Utility: ALK4:ACTRIIB HETEROMULTIMERS AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 3 Jun 2021
Application
Utility: METHODS FOR INCREASING RED BLOOD CELL LEVELS AND TREATING INEFFECTIVE ERYTHROPOIESIS External link
Filling date: 8 Sep 2025 Issue date: 27 May 2021
Application
Utility: TGF-BETA SUPERFAMILY TYPE I AND TYPE II RECEPTOR HETEROMULTIMERS AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 20 May 2021
Application
Utility: ACTRIIB ANTAGONISTS AND DOSING AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 22 Apr 2021
Application
Utility: SINGLE-ARM CO-RECEPTOR FUSION PROTEINS AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 15 Apr 2021
Application
Utility: METHOD OF PROMOTING BONE GROWTH BY AN ANTI-ACTRIIA ANTIBODY External link
Filling date: 8 Sep 2025 Issue date: 11 Feb 2021
Application
Utility: METHODS FOR DOSING AN ACTIVIN-ACTRIIA ANTAGONIST AND MONITORING OF TREATED PATIENTS External link
Filling date: 8 Sep 2025 Issue date: 11 Feb 2021
Application
Utility: COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION External link
Filling date: 8 Sep 2025 Issue date: 28 Jan 2021
Application
Utility: BMPRII POLYPEPTIDES AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 7 Jan 2021

Showing 1 to 50 of 88 patents.